WuXi Biologics (Cayman) Inc (WXXWY)
3.78
-0.07
(-1.93%)
USD |
OTCM |
Nov 21, 16:00
WuXi Biologics Debt to Equity Ratio: 0.0531 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.0531 |
| December 31, 2023 | 0.0532 |
| June 30, 2023 | 0.0746 |
| December 31, 2022 | 0.0794 |
| June 30, 2022 | 0.0835 |
| December 31, 2021 | 0.0856 |
| June 30, 2021 | 0.0974 |
| December 31, 2020 | 0.1267 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.2164 |
| December 31, 2019 | 0.1487 |
| June 30, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| June 30, 2017 | 0.3157 |
| December 31, 2016 | 4.024 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0531
Minimum
Jun 2024
0.2164
Maximum
Jun 2020
0.1019
Average
0.0846
Median
Debt to Equity Ratio Benchmarks
| Zai Lab Ltd | 0.1692 |
| Sinovac Biotech Ltd | 0.0358 |
| CASI Pharmaceuticals Inc | 1.381 |
| Adagene Inc | -- |
| LakeShore Biopharma Co Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.719B |
| Total Liabilities (Quarterly) | 1.577B |
| Shareholders Equity (Quarterly) | 5.594B |
| Current Ratio | 2.911 |
| Net Debt Paydown Yield | 0.59% |